NCT00293072View on ClinicalTrials.gov

Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

May 31, 2005

Conditions
Systemic Lupus ErythematosusANCA Associated Vasculitis
Interventions
DRUG

Rituximab

Trial Locations (1)

CB2 2QQ

Addenbrooke's Hospital, Cambridge

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER

NCT00293072 - Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis | Biotech Hunter | Biotech Hunter